Skip to main content
PMC home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1968 Oct 31;128(5):1137–1155. doi: 10.1084/jem.128.5.1137

MEDIATORS OF INFLAMMATION IN LEUKOCYTE LYSOSOMES

IX. ELASTINOLYTIC ACTIVITY IN GRANULES OF HUMAN POLYMORPHONUCLEAR LEUKOCYTES

A Janoff 1, J Scherer 1
PMCID: PMC2138566  PMID: 5303065

Abstract

The present study demonstrates that a granule fraction derived from human polymorphonuclear leukocytes possesses elastinolytic activity, and that the latter can be separated from the collagenase present in these cells. Properties of the human leukocyte elastase differ sufficiently from those of pancreatic elastases of different species as to suggest that the former enzyme is a distinct and separate entity. Thus, soybean trypsin inhibitor and salivary kallikrein inhibitor (Trasylol) fail to inhibit elastolysis by the pancreatic enzyme, but do inhibit the leukocyte elastinolytic agent. Elastolysis by human leukocyte granule extract does not show significant salt inhibition, whereas that catalyzed by pancreatic elastase is markedly reduced when ionic strength is increased to physiological levels. The leukocyte granule extract is at least 10 times more resistant to serum elastase inhibitor than is the purified pancreatic enzyme. Both enzymes show optimal elastolysis above pH 8.5, but the leukocyte factor still retains 50% of its maximal elastolytic activity at pH 6–7; whereas the activity of the pancreatic enzyme falls to 10% or less of its maximal value under the same conditions. The foregoing characteristics of the human leukocyte elastase suggest that it, rather than pancreatic (serum) elastase, may mediate pathological elastolysis during acute arteritis in man. In keeping with this suggestion, the present experiments also show that elastica staining of human arterial vessels is reduced by incubation of tissues with human leukocyte granule extracts in vitro.

Full Text

The Full Text of this article is available as a PDF (1.1 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BURKE J. S., URIUHARA T., MACMORINE D. R., MOVAT H. Z. A PERMEABILITY FACTOR RELEASED FROM PHAGOCYTOSING PMN-LEUKOCYTES AND ITS INHIBITION BY PROTEASE INHIBITORS. Life Sci. 1964 Dec;3:1505–1512. doi: 10.1016/0024-3205(64)90097-9. [DOI] [PubMed] [Google Scholar]
  2. CHAO S., SCIARRA J. J., VOSBURGH G. J. A spectrophotometric method for determination of elastase and serum elastase inhibitor. Proc Soc Exp Biol Med. 1962 Feb;109:342–345. doi: 10.3181/00379727-109-27196. [DOI] [PubMed] [Google Scholar]
  3. Cochrane C. G., Aikin B. S. Polymorphonuclear leukocytes in immunologic reactions. The destruction of vascular basement membrane in vivo and in vitro. J Exp Med. 1966 Oct 1;124(4):733–752. doi: 10.1084/jem.124.4.733. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. GROB D. Proteolytic enzymes; further studies on protein, polypeptide, and other inhibitors of serum proteinase, leucoproteinase, trypsin, and papain. J Gen Physiol. 1949 Nov;33(2):103–124. doi: 10.1085/jgp.33.2.103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. HALL D. A., CZERKAWSKI J. W. The reaction between elastase and elastic tissue. 4. Soluble elastins. Biochem J. 1961 Jul;80:121–128. doi: 10.1042/bj0800121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. HALPERN B. N. INHIBITION OF THE LOCAL HEMORRHAGIC SHWARTZMAN REACTION BY A POLYPEPTIDE POSSESSING POTENT ANTIPROTEASE ACTIVITY. Proc Soc Exp Biol Med. 1964 Feb;115:273–276. doi: 10.3181/00379727-115-28889. [DOI] [PubMed] [Google Scholar]
  7. Hall D. A. The identification and estimation of elastase in serum and plasma. Biochem J. 1966 Oct;101(1):29–36. doi: 10.1042/bj1010029. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Janoff A., Zeligs J. D. Vascular injury and lysis of basement membrane in vitro by neutral protease of human leukocytes. Science. 1968 Aug 16;161(3842):702–704. doi: 10.1126/science.161.3842.702. [DOI] [PubMed] [Google Scholar]
  9. Kniker W. T., Cochrane C. G. The localization of circulating immune complexes in experimental serum sickness. The role of vasoactive amines and hydrodynamic forces. J Exp Med. 1968 Jan 1;127(1):119–136. doi: 10.1084/jem.127.1.119. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Kono M., Muto M., Hayashi H. Proteases associated with arthus skin lesions: their purification and biological significance (preliminary report). Tohoku J Exp Med. 1968 Mar;94(3):231–235. doi: 10.1620/tjem.94.231. [DOI] [PubMed] [Google Scholar]
  11. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  12. Ling V., Anwar R. A. On the presence of two distinct proteolytic components in pancreatic crystalline elastase. Biochem Biophys Res Commun. 1966 Sep 8;24(5):593–597. doi: 10.1016/0006-291x(66)90363-9. [DOI] [PubMed] [Google Scholar]
  13. MOUNTER L. A., ATIYEH W. Proteases of human leukocytes. Blood. 1960 Jan;15:52–59. [PubMed] [Google Scholar]
  14. PRESS E. M., PORTER R. R., CEBRA J. The isolation and properties of a proteolytic enzyme, cathepsin D, from bovine spleen. Biochem J. 1960 Mar;74:501–514. doi: 10.1042/bj0740501. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. SACHAR L. A., WINTER K. K., SICHER N., FRANKEL S. Photometric method for estimation of elastase activity. Proc Soc Exp Biol Med. 1955 Nov;90(2):323–326. doi: 10.3181/00379727-90-22022. [DOI] [PubMed] [Google Scholar]
  16. THOMAS L. POSSIBLE ROLE OF LEUCOCYTE GRANULES IN THE SHWARTZMAN AND ARTHUS REACTIONS. Proc Soc Exp Biol Med. 1964 Jan;115:235–240. doi: 10.3181/00379727-115-28879. [DOI] [PubMed] [Google Scholar]
  17. THOMAS L. Reversible collapse of rabbit ears after intravenous papain, and prevention of recovery by cortisone. J Exp Med. 1956 Aug 1;104(2):245–252. doi: 10.1084/jem.104.2.245. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. WALFORD R. L., KICKHOEFEN B. Selective inhibition of elastolytic and proteolytic properties of elastase. Arch Biochem Biophys. 1962 Aug;98:191–196. doi: 10.1016/0003-9861(62)90172-8. [DOI] [PubMed] [Google Scholar]
  19. Wasi S., Murray R. K., Macmorine D. R., Movat H. Z. The role of PMN-leucocyte lysosomes in tissue injury, inflammation and hypersensitivity. II. Studies on the proteolytic activity of PMN-leucocyte lysosomes of the rabbit. Br J Exp Pathol. 1966 Aug;47(4):411–423. [PMC free article] [PubMed] [Google Scholar]
  20. Weissmann G., Spilberg I. Breakdown of cartilage proteinpolysaccharide by lysosomes. Arthritis Rheum. 1968 Apr;11(2):162–169. doi: 10.1002/art.1780110206. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES